Anti-snoring Treatment Market to reach $3.8 billion by 2035

Anti - snoring treatment market was valued at $1.9 billion in 2025 and is projected to reach $3.8 billion by 2035, growing at a CAGR of 7.3% during the forecast period (2026-2035). The increasing clinical burden of sleep-disordered breathing, particularly obstructive sleep apnea (OSA), is a primary factor driving demand for anti-snoring treatment solutions. According to data published through medical research supported by public health institutions, OSA affects nearly 1 billion adults globally, indicating a substantial patient base requiring therapeutic intervention. In addition, prevalence estimates suggest that 9% to 38% of the adult population is affected by OSA depending on diagnostic criteria, reflecting a broad and expanding addressable market. Government-backed health statistics further indicate that sleep disorders impact tens of millions of individuals, with estimates showing 50–70 million people in the United States alone suffering from chronic sleep conditions. This rising disease burden is directly influencing demand for both clinical and home-based anti-snoring devices, as early-stage snoring is increasingly recognized as a precursor to more severe respiratory conditions. The strong correlation between snoring and sleep apnea, where a large proportion of snorers are clinically diagnosed with OSA, further strengthens the treatment demand pipeline.

Browse the full report description of “Anti- Snoring Treatment Market Size, Share & Trends Analysis Report by Product Type (Mandibular Advancement Devices (MADs), Nasal Devices, Positive Airway Pressure (PAP) Devices, Chin Straps, Position Control Devices, and Tongue Stabilizing Devices (TSDs)), by Treatment Type (Device-based Treatment, Surgical Treatment, Pharmacological Treatment, and Lifestyle & Behavioral Therapy), by End User (Hospitals, Sleep Clinics & Diagnostic Centers, Homecare Settings, and ENT Clinics), Forecast Period (2026–2035)” at https://www.omrglobal.com/industry-reports/anti-snoring-treatment-market

The market is further supported by a significant gap between diagnosed and untreated cases, creating sustained long-term growth potential. Studies indicate that 80% or more cases of sleep apnea remain undiagnosed, highlighting a large untapped patient population. In key markets such as the United States, recent estimates suggest that over 32% of adults (approximately 83.7 million individuals) are affected by OSA, reinforcing the scale of unmet clinical need. Similar trends are observed in emerging economies, where research indicates that over 100 million individuals in India are affected by OSA, driven by urbanization and lifestyle-related risk factors. The increasing prevalence of obesity, aging populations, and sedentary lifestyles are recognized by public health agencies as major contributors to this trend. As awareness initiatives and diagnostic capabilities improve, a growing proportion of this undiagnosed population is expected to enter the treatment pathway, thereby accelerating adoption of anti-snoring devices and related therapeutic solutions across healthcare systems.

Innovation Leaders Transforming the Anti-snoring Treatment Market

The key players in the anti-snoring treatment market include ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, SomnoMed Limited, ProSomnus Sleep Technologies, Inc., among others. These companies are advancing innovation in anti-snoring treatment solutions through the development of clinically validated oral appliances, next-generation positive airway pressure systems, and digitally enabled therapeutic devices, enabling effective and patient-centric management of sleep-disordered breathing conditions while supporting the growing demand for non-invasive, home-based, and technology-integrated sleep care solutions.

• In October 2025, Smartee Denti-Technology announced the global launch of the Smartee Sleep Aligners, a clear aligner device designed to help manage obstructive sleep apnoea hypopnoea syndrome (OSAHS) and primary snoring (PS). The new series includes two versions such as Smartee SA, which focuses on the treatment of OSAHS and PS, and Smartee SA Plus.

• In March 2024, SnoreLessNow, a Maryland-based company introduced the Anti-snore Mouth Guard+ to the US. This over-the-counter snoring solution is a result of SnoreLessNow’s partnership with Swiss manufacturer Oscimed SA.

Market Coverage

• The market number available for – 2025-2035
• Base year- 2025
• Forecast period- 2026-2035
• Segment Covered-
  • By Product Type
  • By Treatment Type
  • By End User
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape - ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel Healthcare Limited, SomnoMed Limited, ProSomnus Sleep Technologies, Inc., among others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Anti-snoring Treatment Market Report Segment

By Product Type

• Mandibular Advancement Devices (MADs)
• Nasal Devices
• Positive Airway Pressure (PAP) Devices
• Chin Straps
• Position Control Devices
• Tongue Stabilizing Devices (TSDs)

By Treatment Type

• Device-based Treatment
• Surgical Treatment
• Pharmacological Treatment
• Lifestyle & Behavioral Therapy

By End User

• Hospitals
• Sleep Clinics & Diagnostic Centers
• Homecare Settings
• ENT Clinics

Global Anti-snoring Treatment Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Russia
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia and New Zealand
• ASEAN Economies
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/anti-snoring-treatment-market